Schizophrenia Research
Volume 118, Issue 1 , Pages 248-255 , May 2010

Novel immune response to gluten in individuals with schizophrenia

  • Diana Samaroo

      Affiliations

    • Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY, United States
    • ,
  • Faith Dickerson

      Affiliations

    • Sheppard Pratt Health System, Baltimore, MD, United States
    • ,
  • Donald D. Kasarda

      Affiliations

    • Western Regional Research Center, U.S. Department of Agriculture, Albany, CA, United States
    • ,
  • Peter H.R. Green

      Affiliations

    • Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, United States
    • ,
  • Chiara Briani

      Affiliations

    • Department of Neurosciences, University of Padova, Padova, Italy
    • ,
  • Robert H. Yolken

      Affiliations

    • The Stanley Laboratory of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University Medical Center, Baltimore, MD, United States
    • ,
  • Armin Alaedini

      Affiliations

    • Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY, United States
    • Corresponding Author InformationCorresponding author. 1300 York Ave., LC-819, New York, NY 10065, United States.

Received 8 July 2009 ,Revised 7 August 2009 ,Accepted 11 August 2009.

References 

  1. Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann. Intern. Med. 2005;142:289–298
  2. Alaedini A, Green PH. Autoantibodies in celiac disease. Autoimmunity. 2008;41:19–26
  3. Alaedini A, Okamoto H, Briani C, et al. Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J. Immunol. 2007;178:6590–6595
  4. Bender L. Childhood schizophrenia. Psychiatr. Q. 1953;27:663–681
  5. Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun. Rev. 2008;7:644–650
  6. Burk K, Bosch S, Muller CA, et al. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain. 2001;124:1013–1019
  7. Bushara KO. Neurologic presentation of celiac disease. Gastroenterology. 2005;128:S92–S97
  8. Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann. Neurol. 2001;49:540–543
  9. Cascella, N.G., Kryszak, D., Bhatti, B. et al., 2009. Prevalence of Celiac Disease and Gluten Sensitivity in the United States Clinical Antipsychotic Trials of Intervention Effectiveness Study Population. Schizophr Bull. [Epub ahead of print].
  10. Crow MK. Type I interferon in systemic lupus erythematosus. In:  Pitha PM editors. CTMI. Vol. 316:Springer Berlin Heidelberg; 2007;p. 359–386
  11. Dalakas MC. B cells as therapeutic targets in autoimmune neurological disorders. Nat. Clin. Pract. Neurol. 2008;4:557–567
  12. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch. Gen. Psychiatry. 2003;60:466–472
  13. Dohan FC, Martin L, Grasberger JC, Boehme D, Cottrell JC. Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors. Biol. Psychiatry. 1972;5:127–137
  14. Fanciulli G, Dettori A, Tomasi PA, et al. Prolactin and growth hormone response to intracerebroventricular administration of the food opioid peptide gluten exorphin B5 in rats. Life Sci. 2002;71:2383–2390
  15. Fanciulli G, Dettori A, Demontis MP, Tomasi PA, Anania V, Delitala G. Gluten exorphin B5 stimulates prolactin secretion through opioid receptors located outside the blood–brain barrier. Life Sci. 2005;76:1713–1719
  16. Graff H, Handford A. Celiac syndrome in the case histories of five schizophrenics. Psychiatr. Q. 1961;35:306–313
  17. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582–1585
  18. Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol. Rev. 2005;206:219–231
  19. Jin SZ, Xu Q, Wu N, et al. A study of gluten antibody levels in serum among patients with schizophrenia. Schizophr. Res. 2008;98:S145
  20. Jungerius BJ, Bakker SC, Monsuur AJ, Sinke RJ, Kahn RS, Wijmenga C. Is MYO9B the missing link between schizophrenia and celiac disease?. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;147:351–355
  21. Kalaydjian AE, Eaton W, Cascella N, Fasano A. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr. Scand. 2006;113:82–90
  22. Lambert MT, Bjarnason I, Connelly J, et al. Small intestine permeability in schizophrenia. Br. J. Psychiatry. 1989;155:619–622
  23. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens. 2003;61:105–117
  24. Ludvigsson JF, Osby U, Ekbom A, Montgomery SM. Coeliac disease and risk of schizophrenia and other psychosis: a general population cohort study. Scand. J. Gastroenterol. 2007;42:179–185
  25. Monsuur AJ, de Bakker PI, Alizadeh BZ, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat. Genet. 2005;37:1341–1344
  26. Mothes T. Deamidated gliadin peptides as targets for celiac disease-specific antibodies. Adv. Clin. Chem. 2007;44:35–63
  27. Naiyer AJ, Hernandez L, Ciaccio EJ, et al. Comparison of commercially available serologic kits for the detection of celiac disease. J. Clin. Gastroenterol. 2009;43:225–232
  28. Nawa H, Takei N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci. Res. 2006;56:2–13
  29. Patterson PH. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 2008;[Epub ahead of print]
  30. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;[Epub ahead of print]
  31. Raveche ES, Schutzer SE, Fernandes H, et al. Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis. J. Clin. Microbiol. 2005;43:850–856
  32. Reichelt KL, Landmark J. Specific IgA antibody increases in schizophrenia. Biol. Psychiatry. 1995;37:410–413
  33. Reinton N, Helgheim A, Shegarfi H, Moghaddam A. A one-step real-time PCR assay for detection of DQA1*05, DQB1*02 and DQB1*0302 to aid diagnosis of celiac disease. J. Immunol. Methods. 2006;316:125–132
  34. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002
  35. Schwertz E, Kahlenberg F, Sack U, et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin. Chem. 2004;50:2370–2375
  36. Shi J, Levinson DF, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009;[Epub ahead of print]
  37. Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr. Res. 2008;106:268–274
  38. Sollid LM. Molecular basis of celiac disease. Annu. Rev. Immunol. 2000;18:53–81
  39. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature. 2009;[Epub ahead of print]
  40. Takahashi M, Fukunaga H, Kaneto H, Fukudome S, Yoshikawa M. Behavioral and pharmacological studies on gluten exorphin A5, a newly isolated bioactive food protein fragment, in mice. Jpn. J. Pharmacol. 2000;84:259–265
  41. Torrey EF, Yolken RH. The schizophrenia–rheumatoid arthritis connection: infectious, immune, or both?. Brain Behav. Immun. 2001;15:401–410
  42. Wei J, Hemmings GP. Gene, gut and schizophrenia: the meeting point for the gene−environment interaction in developing schizophrenia. Med. Hypotheses. 2005;64:547–552
  43. Wood NC, Hamilton I, Axon AT, et al. Abnormal intestinal permeability. An aetiological factor in chronic psychiatric disorders?. Br. J. Psychiatry. 1987;150:853–856
  44. Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc. Natl. Acad. Sci. U S A. 2004;101:11404–11409

PII: S0920-9964(09)00385-5

doi: 10.1016/j.schres.2009.08.009

Schizophrenia Research
Volume 118, Issue 1 , Pages 248-255 , May 2010

Article Tools

* Image Usage & Resolution